Back to results
US 2022/0313709 A1Published application
Spironolactone Aqueous Compositions
AssigneeCmp Development LLC
InventorsAnthony Pipho, Michael Paul DeHart
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a stable, ready-to-use liquid formulation comprising spironolactone and its method of use.
Claims23
A process for preparing a pharmaceutical composition, which comprises:
- (a) mixing in a first container a first composition comprising a hydrocolloid, an anti-foaming agent, a preservative, and water;
- (b) mixing in a second container a second composition comprising micronized spironolactone glycerin, and water;
- (c) transferring the second composition from the second container to the first container followed by mixing to obtain a third composition;
- and
- (d) adding a flavoring agent and water to the first container from step (c) to obtain a fourth composition;
- wherein the pharmaceutical composition comprises 5 mg/mL micronized spironolactone;
- and
- wherein the pharmaceutical composition comprises from 18 mg/mL to 24 mg/mL glycerin.
5 more elements
Dependencies are inferred from the claim text.